Atlas Trials

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

Clinical trial NCT06855823 · RECRUITING

Trial details

NCT number
NCT06855823
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Start date
2025-01-14
Primary completion
2026-12-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.